Shares of Chemed Corp. (CHE) surged 7.07% in Thursday's pre-market trading, following the company's better-than-expected fourth-quarter earnings results.
The healthcare services provider reported adjusted earnings per share of $6.83 for the quarter ended December 31, beating analysts' average estimate of $6.78. Revenue grew 9.2% year-over-year to $639.99 million, also surpassing expectations of $636.10 million.
Chemed's solid quarterly performance, highlighted by earnings and revenue beats, appears to be the primary driver behind the stock's significant pre-market rally. The company's strong results underscore its continued growth momentum and operational efficiency.